Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LINGO1 Antikörper (N-Term)

LINGO1 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN543819
  • Target Alle LINGO1 Antikörper anzeigen
    LINGO1 (Leucine Rich Repeat and Ig Domain Containing 1 (LINGO1))
    Bindungsspezifität
    • 15
    • 14
    • 13
    • 11
    • 10
    • 9
    • 7
    • 6
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 61
    • 37
    • 20
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 76
    Kaninchen
    Klonalität
    • 76
    Polyklonal
    Konjugat
    • 25
    • 8
    • 7
    • 7
    • 6
    • 6
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser LINGO1 Antikörper ist unkonjugiert
    Applikation
    • 44
    • 43
    • 30
    • 13
    • 13
    • 10
    • 7
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Verwendungszweck
    Rabbit polyclonal antibody raised against synthetic peptide of LINGO1.
    Kreuzreaktivität
    Human
    Immunogen
    A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human LINGO1.
    Top Product
    Discover our top product LINGO1 Primärantikörper
  • Applikationshinweise
    Western Blot (1:1000)
    Immunohistochemistry (1:10-50)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In PBS (0.09 % sodium azide)
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Satoh, Tabunoki, Yamamura, Arima, Konno: "TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions." in: Neuropathology and applied neurobiology, Vol. 33, Issue 1, pp. 99-107, (2007) (PubMed).

    Inoue, Lin, Lee, Shao, Mendes, Snodgrass-Belt, Sweigard, Engber, Pepinsky, Yang, Beal, Mi, Isacson: "Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 36, pp. 14430-5, (2007) (PubMed).

    Mosyak, Wood, Dwyer, Buddha, Johnson, Aulabaugh, Zhong, Presman, Benard, Kelleher, Wilhelm, Stahl, Kriz, Gao, Cao, Ling, Pangalos, Walsh, Somers: "The structure of the Lingo-1 ectodomain, a module implicated in central nervous system repair inhibition." in: The Journal of biological chemistry, Vol. 281, Issue 47, pp. 36378-90, (2006) (PubMed).

  • Target
    LINGO1 (Leucine Rich Repeat and Ig Domain Containing 1 (LINGO1))
    Andere Bezeichnung
    LINGO1 (LINGO1 Produkte)
    Synonyme
    lern1 antikoerper, lrrn6a antikoerper, unq201 antikoerper, DKFZp459P0736 antikoerper, LERN1 antikoerper, LRRN6A antikoerper, UNQ201 antikoerper, 4930471K13Rik antikoerper, AV148400 antikoerper, LINGO-1 antikoerper, Lrrn6a antikoerper, leucine rich repeat and Ig domain containing 1 antikoerper, LINGO1 antikoerper, lingo1 antikoerper, Lingo1 antikoerper
    Gen-ID
    84894
Sie sind hier:
Kundenservice